SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

Correspondence 0001683168-24-000914 from MCI Income Fund VII, LLC (CIK 0001954416)

MCI Income Fund VII, LLC (CIK 0001954416)
Date: Feb. 13, 2024 · CIK: 0001954416 · Accession: 0001683168-24-000914

AI Filing Summary & Sentiment

File numbers found in text: 024-12073

Date
January 26, 2024
Author
/s/ Charles McCarthy
Form
CORRESP
Company
MCI Income Fund VII, LLC (CIK 0001954416)

Letter

Via EDGAR Division of Corporation Finance Office of Real Estate & Construction United States Securities and Exchange Commission Amendment No. 7 on Form 1-A Initially Filed January 26, 2024 File No. 024-12073 CIK: 0001954416

Dear Mr. Alper:

This letter is submitted on behalf of MCI Income Fund VII, LLC, a Delaware limited liability company (the “Issuer”), in response to comments received from the staff of the Division of Corporation Finance (the “Staff”) of the United States Securities and Exchange Commission (the “Commission”) in a letter (the “Comment Letter”) dated February 6, 2024 with respect to the Issuer’s Amendment No. 6 to Offering Statement on Form 1-A (File No. 024-12073), filed with the Commission on January 26, 2024; the First Amendment to the Issuer’s Offering Statement on Form 1-A/A, filed with the Commission on January 5, 2023; the Second Amendment to the Issuer’s Offering Statement on Form 1-A/A, filed with the Commission on March 23, 2023; the Third Amendment to the Issuer’s Offering Statement on Form 1-A/A, filed with the Commission on June 21, 2023; the Fourth Amendment to the Issuer’s Offering Statement on Form 1-A/A, filed with the Commission on November 13, 2023; and the Fifth Amendment to the Issuer’s Offering Statement on Form 1-A/A, filed with the Commission on December 14, 2023 (together, the “Offering Statement”). This letter is being submitted contemporaneously with the filing of the seventh amendment of the Offering Statement (the “Seventh Amendment”) containing changes made in response to the Staff’s comments and for the purpose of updating and revising certain information in the Offering Statement. Certain capitalized terms set forth in this letter are used as defined in the Third Amendment.

For ease of reference, the Staff’s comments contained in the Comment Letter are reprinted below in bold, numbered to correspond with the paragraph number assigned in the Comment Letter, and is followed by the corresponding response of the Issuer.

1) Please revise your interim financial statements to include statements of comprehensive income and statements of cash flows for the comparable period of the preceding fiscal year (i.e., the period from August 26, 2022 (Inception) through September 30, 2022) and to include the footnote disclosures required by GAAP.

Issuer’s Response: The Issuer directs the Staff to the revised exhibits set forth on F-2 – F-7 under “Financial Statements” to include statements of comprehensive income and statements of cash flows for the comparable period of the preceding fiscal year and to include the footnote disclosures required by GAAP.

2) Please revise your signatures page to include the statement “This offering statement has been signed by the following persons in the capacities and on the dates indicated” above the appropriate signatures.

Issuer’s Response: The Issuer directs the Staff to the revised Signatures Page on page [III-2] of the Amendment.

Sincerely,
/s/ Charles McCarthy

Show Raw Text
CORRESP
1
filename1.htm

February [__], 2024

Via EDGAR

Richard Alper

Division of Corporation Finance

Office of Real Estate & Construction

United States Securities and Exchange Commission

100 F Street, N.E.

Washington, DC 20549

 Re: MCI Income Fund VII, LLC

    Amendment No. 7 on Form 1-A

    Initially Filed January 26, 2024

    File No. 024-12073

    CIK: 0001954416

Dear Mr. Alper:

This letter
is submitted on behalf of MCI Income Fund VII, LLC, a Delaware limited liability company (the “Issuer”), in response
to comments received from the staff of the Division of Corporation Finance (the “Staff”) of the United States Securities
and Exchange Commission (the “Commission”) in a letter (the “Comment Letter”) dated February 6,
2024 with respect to the Issuer’s Amendment No. 6 to Offering Statement on Form 1-A (File No. 024-12073), filed with the Commission
on January 26, 2024; the First Amendment to the Issuer’s Offering Statement on Form 1-A/A, filed with the Commission on January
5, 2023; the Second Amendment to the Issuer’s Offering Statement on Form 1-A/A, filed with the Commission on March 23, 2023; the
Third Amendment to the Issuer’s Offering Statement on Form 1-A/A, filed with the Commission on June 21, 2023; the Fourth Amendment
to the Issuer’s Offering Statement on Form 1-A/A, filed with the Commission on November 13, 2023; and the Fifth Amendment to the
Issuer’s Offering Statement on Form 1-A/A, filed with the Commission on December 14, 2023 (together, the “Offering Statement”).
This letter is being submitted contemporaneously with the filing of the seventh amendment of the Offering Statement (the “Seventh
Amendment”) containing changes made in response to the Staff’s comments and for the purpose of updating and revising certain
information in the Offering Statement. Certain capitalized terms set forth in this letter are used as defined in the Third Amendment.

For ease of
reference, the Staff’s comments contained in the Comment Letter are reprinted below in bold, numbered to correspond with the paragraph
number assigned in the Comment Letter, and is followed by the corresponding response of the Issuer.

 1) Please revise your interim financial statements to include statements of comprehensive income and statements of cash flows for
the comparable period of the preceding fiscal year (i.e., the period from August 26, 2022 (Inception) through September 30, 2022) and
to include the footnote disclosures required by GAAP.

Issuer’s
Response: The Issuer directs the Staff to the revised exhibits set forth on F-2 – F-7 under “Financial Statements”
to include statements of comprehensive income and statements of cash flows for the comparable period of the preceding fiscal year and
to include the footnote disclosures required by GAAP.

 2) Please revise your signatures page to include the statement “This offering statement has been signed by the following persons
in the capacities and on the dates indicated” above the appropriate signatures.

Issuer’s
Response: The Issuer directs the Staff to the revised Signatures Page on page [III-2] of the Amendment.

  Sincerely,

  /s/ Charles McCarthy

  Charles McCarthy

  Associate